What is Eli Lilly's other — revenue?

Eli Lilly (LLY) reported other — revenue of $187M in Q1 2026.

What does other — revenue mean?

This metric represents the total net sales generated from products or services that do not fall into the company's primary therapeutic or reporting segments. It captures revenue from legacy assets, non-core business lines, or smaller product portfolios that are not individually material enough to warrant separate disclosure. Monitoring this figure helps investors understand the tail-end revenue contribution from older or non-strategic parts of the business portfolio.

Eli Lilly LLY Other — Revenue

Similar metrics at other companies

CONOther — Revenue

$12.46M+10.4%

TPCOther — Revenue

$81.22M+11.6%

DOCSOther — Revenue

$9.68M+51.6%

LAUROther — Revenue

$57.48M+13.4%

NNIOther — Revenue

$580K+2,048%

APPFOther — Revenue

$2.63M-24.5%

Other financials

Income statement

See full

Revenue$19.8B+55.5%

Gross profit$16.2B+54.4%

Net income$7.4B+168%

EPS (diluted)$8.26+170%

Balance sheet

See full

Cash & equivalents$5.3B+70.8%

Total debt$43.4B+12.6%

Total equity$31.2B+97.9%

Total assets$116.58B+30.4%

Cash flow

See full

Operating cash flow$5.3B+220%

CapEx$2.3B+54.0%

Free cash flow$3.0B+1,828%

Valuation

See full

Market cap$987.23B+10.8%

Enterprise value$1.03T+10.6%

P/E39.1×-41.2×

P/S13.7×-4.5×

Profitability

See full

Gross margin82.8%+1.1pp

Net margin35%+12.3pp

FCF margin16.4%+8.7pp

Returns & leverage

See full

Return on equity107.6%+29.9pp

Debt / equity1.4×-1.1×

Current ratio1.5×+0.1×

Where this comes from

Reported directly by Eli Lilly in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: Eli Lilly’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Eli Lilly's other — revenue.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Eli Lilly's other — revenue?: Eli Lilly (LLY) reported other — revenue of $187M in Q1 2026.
What does other — revenue mean?: This metric represents the total net sales generated from products or services that do not fall into the company's primary therapeutic or reporting segments. It captures revenue from legacy assets, non-core business lines, or smaller product portfolios that are not individually material enough to warrant separate disclosure. Monitoring this figure helps investors understand the tail-end revenue contribution from older or non-strategic parts of the business portfolio.